U Pharmacotherapy Outcomes Research Center to Host National Summit on Medicaid

U Pharmacotherapy Outcomes Research Center to Host National Summit on Medicaid

Sep 22, 2004 6:00 PM

The role of evidence-based medicine, quality assessment, and prescription drug coverage are among the topics to be addressed at a nationwide Medicaid Summit hosted by the University of Utah Pharmacotherapy Outcomes Research Center.

The summit, Sept. 30-Oct. 2 at the Canyons Resort in Park City, will gather nearly 100 experts from across the country to address policy development and procedures surrounding the 2003 Medicaid Modernization Act and its 2006 implementation. State Medicaid officers, managed Medicaid health plan representatives, and academic outcomes researchers were invited to the three-day summit to discuss new Medicaid programs and exchange ideas and opinions.

The summit will give those who work in the Medicaid system the opportunity to frame the issues and facilitate dialogue on potential solutions, according to Diana I. Brixner, R.Ph., Ph.D., associate professor and chair of the U College of Pharmacy's Department of Pharmacotherapy and executive director of the Pharmacotherapy Outcomes Research Center.

"We have gathered speakers with national and international stature to present and lead interactive discussions," Brixner said. "We also plan to present examples from three states as to how their covered populations may change as patients previously covered by both Medicaid and Medicare will now move to Medicare coverage for their prescription drugs."

Participants can obtain up to 13 hours of continuing education credits in pharmacy by attending the summit.

The summit's primary sponsors are Amgen, Eli Lilly and Company, Pfizer, and TAP Pharmaceuticals. Other sponsors include AstraZeneca International, Aventis Pharmaceuticals, and RxAmerica.

The Pharmacotherapy Outcomes Research Center, part of the U of U Health Sciences Center, conducts outcomes research studies that demonstrate the value of drug therapy in the treatment of disease. The center contracts with industry, foundations, managed care organizations, and government agencies to conduct research and training in economic evaluations and patient-reported outcomes involving pharmacotherapy.

# # #

Visit our News Archive for a complete list of previous News.